|
Basal subtype and clinical estrogen receptor status of genomically basal breast tumors in Caucasian, African American, and Latin American patients. |
|
|
Honoraria - AstraZeneca; Celgene; Eisai; Genentech; Genomic Health; Novartis; Pfizer; Puma Biotechnology |
Consulting or Advisory Role - Amgen; AstraZeneca; Athenex; Celldex; Eisai; Puma Biotechnology |
Speakers' Bureau - Celgene; Eisai; Genentech; Genomic Health; Novartis; Pfizer; Puma Biotechnology |
|
|
|
Travel, Accommodations, Expenses - Agendia |
|
|
Consulting or Advisory Role - AstraZeneca; Pfizer; Puma Biotechnology |
Speakers' Bureau - Genentech/Roche |
Travel, Accommodations, Expenses - Genentech/Roche; Pfizer |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No Relationships to Disclose |